Laura Soucek (IMAGE)
Caption
Laura Soucek, corresponding author of this present study, Principal Investigator of VHIO's Models of Cancer Therapies Group, Co-Founder & Chief Executive Officer (CEO) of Peptomyc, and an ICREA Research Professor.
Credit
Vall d'Hebron Institute of Oncology (VHIO).
Usage Restrictions
No restrictions.
License
Public Domain